Speakers: Stuart Schreiber, Jay Bradner, Aly Shamji, Mike Foley, and Brian Hubbard

Insights from human genomes reveal hints to basic questions about our origins and evolutionary history. But can this focus on human biology provide guideposts to revolutionary therapies? Leaders from the Broad’s Center for the Science of Therapeutics (CSofT) will discuss the institute’s current efforts and future aspirations for therapeutics research. The panel will describe "chemistry-enabled, patient-based drug discovery" and will lead an interactive discussion on how we might mitigate suffering from disease in the future.